CA2157376A1 - Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle - Google Patents

Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle

Info

Publication number
CA2157376A1
CA2157376A1 CA002157376A CA2157376A CA2157376A1 CA 2157376 A1 CA2157376 A1 CA 2157376A1 CA 002157376 A CA002157376 A CA 002157376A CA 2157376 A CA2157376 A CA 2157376A CA 2157376 A1 CA2157376 A1 CA 2157376A1
Authority
CA
Canada
Prior art keywords
vaccine compositions
monophosphoryl lipid
compositions containing
deacylated monophosphoryl
deacylated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002157376A
Other languages
English (en)
Other versions
CA2157376C (fr
Inventor
Pierre Hauser
Pierre Voet
Moncef Slaoui
Nathalie Marie-Josephe Garcon-Johnson
Pierre Desmons
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939306029A external-priority patent/GB9306029D0/en
Priority claimed from GB9403417A external-priority patent/GB9403417D0/en
Application filed by Individual filed Critical Individual
Priority to CA002555911A priority Critical patent/CA2555911C/fr
Priority claimed from PCT/EP1994/000818 external-priority patent/WO1994021292A1/fr
Publication of CA2157376A1 publication Critical patent/CA2157376A1/fr
Application granted granted Critical
Publication of CA2157376C publication Critical patent/CA2157376C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
CA002157376A 1993-03-23 1994-03-14 Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle Expired - Lifetime CA2157376C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA002555911A CA2555911C (fr) 1993-03-23 1994-03-14 Compositions d'adjuvant contenant le lipide a monophosphoryle 3-o-deacetyle

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9306029.1 1993-03-23
GB939306029A GB9306029D0 (en) 1993-03-23 1993-03-23 Vaccine compositions
GB9403417A GB9403417D0 (en) 1994-02-23 1994-02-23 Vaccine compositions
GB9403417.0 1994-02-23
PCT/EP1994/000818 WO1994021292A1 (fr) 1993-03-23 1994-03-14 Compositions vaccinales renfermant le lipide a monophosphorylique 3-o desacetyle

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CA002555911A Division CA2555911C (fr) 1993-03-23 1994-03-14 Compositions d'adjuvant contenant le lipide a monophosphoryle 3-o-deacetyle

Publications (2)

Publication Number Publication Date
CA2157376A1 true CA2157376A1 (fr) 1994-09-29
CA2157376C CA2157376C (fr) 2006-10-31

Family

ID=37394902

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002157376A Expired - Lifetime CA2157376C (fr) 1993-03-23 1994-03-14 Compositions de vaccin contenant du derive 3-o-desacetyle du lipide a monophosphoryle

Country Status (1)

Country Link
CA (1) CA2157376C (fr)

Also Published As

Publication number Publication date
CA2157376C (fr) 2006-10-31

Similar Documents

Publication Publication Date Title
CA2192659A1 (fr) Compositions d'adjuvant comprenant un sel mineral et un autre compose immunostimulateur
AU2001228521A1 (en) IR absorbing compositions
CA2152615A1 (fr) Compositions pharmaceutiques a base d'atovaquone
AU8146691A (en) Preparation process of sustained release compositions and the compositions thus obtained
AU5226990A (en) Orally administrable ibuprofen compositions
CA2059432A1 (fr) Nanoparticules de medicament modifie en surface
AU4684989A (en) Certified weigher-short paid mail
CA2217178A1 (fr) Vaccins contenant une saponine ainsi qu'un sterol
AU5072890A (en) Fungal formulation for biocontrol of soilborne plant pathogens
AU5491290A (en) Perfume particles for use in cleaning and conditioning compositions
AU2616292A (en) Perfume particles
CA2172507A1 (fr) Procedes et compositions de microencapsulation d'adjuvants
AU7890487A (en) Impact resistant polymeric compositions and process for the preparation thereof
CA2151967A1 (fr) Compositions magnetiques nanocomposites et procedes de fabrication connexes
AU7530387A (en) Thermoplastic compositions and process for the preparation thereof
AU5279393A (en) Excipient having high compactability and prccess for preparing the same
CA2177668A1 (fr) Compositions de vaccin pour mammiferes comprenant un adjuvant constitue de squalene ou de squalane, de glycerol et d'un surfactant
AU644409B2 (en) Cross-linkable polyester/isocyanate compositions suited for the preparation of composite materials
AU2951489A (en) Improving the stability of pharmaceutical compositions
AU3056092A (en) Compositions of difluoromethane and tetrafluoroethane
AU4449593A (en) Coal pulverizer purifier classifier
CA2111758A1 (fr) Compositions pour soins d'hygiene personnelle
IE883325L (en) Silica for use in dentifrice compositions
AU657334B2 (en) Anti-glaucoma compositions
CA2150565A1 (fr) Compositions mixtes extraites de l'enveloppe de psyllium pour la preparation de boissons

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20140314